Quick Takeaways
- ADAR1 Capital Management, LLC filed SCHEDULE 13G/A for Cellectar Biosciences, Inc. Common Stock, $0.00001 par value per share (CLRB).
- Disclosed ownership: 0.1%.
- Date of event: 30 Jun 2025.
ADAR1 Capital Management, LLC - 30 Jun 2025 SCHEDULE 13G/A Report for Cellectar Biosciences, Inc. Common Stock, $0.00001 par value per share (CLRB)
- Filing Manager
- ADAR1 Capital Management, LLC
- Reporting Manager
- ADAR1 Capital Management, LLC
- Symbol
- CLRB
- Disclosed Ownership
- 2,962 shares
- Ownership
- 0.1%
- Form type
- SCHEDULE 13G/A
- Filing time
- 14 Aug 2025, 19:39:18 UTC
- Date of event
- 30 Jun 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"ADAR1 Capital Management, LLC disclosed 0.1% ownership in Cellectar Biosciences, Inc. Common Stock, $0.00001 par value per share (CLRB) on 30 Jun 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 14 Aug 2025, 19:39.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (4)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| ADAR1 Capital Management, LLC | 0.1% | 2,962 | 0 | 2,962 | /s/ Daniel Schneeberger | Daniel Schneeberger, Manager | |
| ADAR1 Capital Management GP, LLC | 0.1% | 2,540 | 0 | 2,540 | /s/ Daniel Schneeberger | Daniel Schneeberger, Manager | |
| Daniel Schneeberger | 0.1% | 2,962 | 0 | 2,962 | /s/ Daniel Schneeberger | Daniel Schneeberger, in his individual capacity | |
| ADAR1 Partners, LP | 0% | 0 | 0 | 0 | /s/ Daniel Schneeberger | Manager of ADAR1 Capital Management GP, LLC, the General Partner of ADAR1 Partners, LP |